{"cited_by_count":355872,"description":"This cluster of papers focuses on the classification, staging, treatment, and prognosis of cutaneous lymphomas, with a specific emphasis on mycosis fungoides and S\u00e9zary syndrome. It includes discussions on the WHO-EORTC classification, survival outcomes, prognostic factors, and various treatment options such as bexarotene and denileukin diftitox. The cluster also addresses the incidence patterns, genomic landscape, and molecular profiling of cutaneous T-cell lymphomas.","display_name":"Cutaneous lymphoproliferative disorders research","domain_id":"4","external_ids":{"openalex":"https://openalex.org/T11811","wikipedia":"https://en.wikipedia.org/wiki/Cutaneous_lymphoma"},"field_id":"27","id":"T11811","keywords":[{"display_name":"cutaneous T-cell lymphoma","id":"cutaneous-t-cell-lymphoma","score":0.7036,"url":"https://openalex.org/keywords/cutaneous-t-cell-lymphoma"},{"display_name":"mycosis fungoides","id":"mycosis-fungoides","score":0.817,"url":"https://openalex.org/keywords/mycosis-fungoides"},{"display_name":"S\u00e9zary syndrome","id":"sezary-syndrome","score":0.8441,"url":"https://openalex.org/keywords/sezary-syndrome"},{"display_name":"cutaneous lymphoma","id":"cutaneous-lymphoma","score":0.4525,"url":"https://openalex.org/keywords/cutaneous-lymphoma"},{"display_name":"lymphomatoid papulosis","id":"lymphomatoid-papulosis","score":0.6444,"url":"https://openalex.org/keywords/lymphomatoid-papulosis"},{"display_name":"primary cutaneous lymphoma","id":"primary-cutaneous-lymphoma","score":0.8568,"url":"https://openalex.org/keywords/primary-cutaneous-lymphoma"},{"display_name":"skin lymphoma","id":"skin-lymphoma","score":0.7142,"url":"https://openalex.org/keywords/skin-lymphoma"},{"display_name":"cutaneous B-cell lymphoma","id":"cutaneous-b-cell-lymphoma","score":0.853,"url":"https://openalex.org/keywords/cutaneous-b-cell-lymphoma"},{"display_name":"primary cutaneous T-cell lymphoma","id":"primary-cutaneous-t-cell-lymphoma","score":0.7871,"url":"https://openalex.org/keywords/primary-cutaneous-t-cell-lymphoma"},{"display_name":"primary cutaneous B-cell lymphoma","id":"primary-cutaneous-b-cell-lymphoma","score":0.9298,"url":"https://openalex.org/keywords/primary-cutaneous-b-cell-lymphoma"},{"display_name":"primary cutaneous anaplastic large cell lymphoma","id":"primary-cutaneous-anaplastic-large-cell-lymphoma","score":0.8739,"url":"https://openalex.org/keywords/primary-cutaneous-anaplastic-large-cell-lymphoma"},{"display_name":"subcutaneous panniculitis-like T-cell lymphoma","id":"subcutaneous-panniculitis-like-t-cell-lymphoma","score":0.7314,"url":"https://openalex.org/keywords/subcutaneous-panniculitis-like-t-cell-lymphoma"},{"display_name":"extracorporeal photopheresis","id":"extracorporeal-photopheresis","score":0.2106,"url":"https://openalex.org/keywords/extracorporeal-photopheresis"},{"display_name":"bexarotene","id":"bexarotene","score":0.3184,"url":"https://openalex.org/keywords/bexarotene"},{"display_name":"epidermotropism","id":"epidermotropism","score":0.7383,"url":"https://openalex.org/keywords/epidermotropism"},{"display_name":"mogamulizumab","id":"mogamulizumab","score":0.415,"url":"https://openalex.org/keywords/mogamulizumab"},{"display_name":"S\u00e9zary cells","id":"sezary-cells","score":0.8754,"url":"https://openalex.org/keywords/sezary-cells"},{"display_name":"folliculotropic mycosis fungoides","id":"folliculotropic-mycosis-fungoides","score":0.9605,"url":"https://openalex.org/keywords/folliculotropic-mycosis-fungoides"},{"display_name":"large cell transformation","id":"large-cell-transformation","score":0.7477,"url":"https://openalex.org/keywords/large-cell-transformation"},{"display_name":"cutaneous pseudolymphoma","id":"cutaneous-pseudolymphoma","score":0.7517,"url":"https://openalex.org/keywords/cutaneous-pseudolymphoma"},{"display_name":"total skin electron beam therapy","id":"total-skin-electron-beam-therapy","score":0.7697,"url":"https://openalex.org/keywords/total-skin-electron-beam-therapy"},{"display_name":"primary cutaneous follicle center lymphoma","id":"primary-cutaneous-follicle-center-lymphoma","score":0.9333,"url":"https://openalex.org/keywords/primary-cutaneous-follicle-center-lymphoma"},{"display_name":"primary cutaneous diffuse large B-cell lymphoma","id":"primary-cutaneous-diffuse-large-b-cell-lymphoma","score":0.891,"url":"https://openalex.org/keywords/primary-cutaneous-diffuse-large-b-cell-lymphoma"},{"display_name":"primary cutaneous marginal zone lymphoma","id":"primary-cutaneous-marginal-zone-lymphoma","score":0.9301,"url":"https://openalex.org/keywords/primary-cutaneous-marginal-zone-lymphoma"},{"display_name":"follicular mucinosis","id":"follicular-mucinosis","score":0.4057,"url":"https://openalex.org/keywords/follicular-mucinosis"}],"legacy_keywords":["Cutaneous Lymphomas","Mycosis Fungoides","S\u00e9zary Syndrome","EORTC Classification","T-Cell Lymphoma","CD30+ Lymphoproliferative Disorders","Primary Cutaneous Lymphomas","Bexarotene Treatment","Prognostic Factors","Clinical End Points"],"openalex_id":"https://openalex.org/T11811","source_created_date":"2024-01-23T15:27:11","source_updated_date":"2026-10-17T03:02:00","subfield_id":"2708","url":"/topics/T11811","works_api_url":"https://api.openalex.org/works?filter=topics.id:T11811","works_count":29080,"label":"Cutaneous lymphoproliferative disorders research","provider":"openalex","revision":"a1de5ad8842ada72","taxonomy_revision":"f050b5d4780b1289","title":"Cutaneous lymphoproliferative disorders research","kind":"topic-directory","aeo_cohort":"topic-directory","catalogue_revision":"f050b5d4780b1289","numeric_address":"36249525060773290","address_version":"morton4x16-v1","coordinates":[4,27,2708,11811],"answer_status":"Directory metadata; local answer requires separate source review","truth_status":"Subject descriptor, not a factual answer or a demonstrated knowledge gap","reviewed_answer":null}